TAOX NASDAQ
TAOâ¯Synergies Inc.
1W: -5.7%
1M: -3.6%
3M: -29.9%
YTD: -22.1%
1Y: -59.0%
$3.38
-0.08 (-2.31%)
Weekly Expected Move ±9.8%
$3
$3
$3
$4
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$11.1M
52W Range3.18-10
Volume130,073
Avg Volume124,687
Beta1.43
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJoshua N. Silverman
Employees4
SectorHealthcare
IndustryBiotechnology
IPO Date2025-07-02
Websitetaosynergies.com
1185 Avenue of the Americas, 3rdâ¯Floor
New York, NY 10036
US
New York, NY 10036
US
About TAOâ¯Synergies Inc.
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
Latest News
US Stocks Mixed; Dow Falls Over 100 Points
12 Information Technology Stocks Moving In Friday's Pre-Market Session
12 Information Technology Stocks Moving In Wednesday's Pre-Market Session
12 Information Technology Stocks Moving In Tuesday's Intraday Session
12 Information Technology Stocks Moving In Friday's Intraday Session
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Silverman Joshua | A-Award | 200,000 | $4.80 | 2026-05-18 |
| Bernstein Bruce | A-Award | 55,000 | $4.80 | 2026-05-18 |
| Singer William S. | A-Award | 35,000 | $4.80 | 2026-05-18 |
| WEINSTEIN ROBERT | A-Award | 30,000 | $4.80 | 2026-05-18 |
| Ephron Robert | A-Award | 10,000 | $4.80 | 2026-05-18 |